A record of what Arvind Sanger said publicly, with the source. Not advice.
Pending — not yet graded
“Bearish on Indian pharmaceutical companies that rely heavily on exports to the US. Trump's announced tariff hikes, eventually reaching 250% over the next 12 months, create a significant headwind for the sector, although the market has already factored in some of this negative impact.”
Nifty PharmaBearishCalled 06 Aug 2025
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.
Read the original articleSee Arvind Sanger’s full track record